Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine versus sufentanil with propofol for anesthesia in hysteroscopic surgery
ChiCTR2600133608Phase 4Not yet recruiting
- Sponsor
- Tsinghua University Yuquan Hospital
- Start
- Oct 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine, sufentanil and propofol in hysteroscopic surgery (2 arms), sponsored by Tsinghua University Yuquan Hospital. Primary endpoint: Incidence of intraoperative respiratory depression. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
esketaminesufentanilpropofol
03
Conditions
hysteroscopic surgery
Beyond the preview
Go deeper on ChiCTR2600133608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133608.